Evidence map›Paper›PMID 31490936›Full record

ArticlePloS one2019

The Arabian camel, Camelus dromedarius interferon epsilon: Functional expression, in vitro refolding, purification and cytotoxicity on breast cancer cell lines.

Manal Abdel-Fattah, Hesham Saeed, Lamiaa El-Shennawy, Manal Shalaby, Amira Embaby, Farid Ataya, Hoda Mahmoud, Ahmed Hussein

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Recent Advances in Camel Immunology.Frontiers in immunology · 2020
    Pooled it
  2. Article
  3. Review
  4. Interferon Epsilon: Properties and Functions.Current molecular medicine · 2025
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Manal Abdel-FattahDepartment of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Alexandria, Egypt.
Hesham SaeedDepartment of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Alexandria, Egypt.ORCID 0000-0001-6600-1338
Lamiaa El-ShennawyDepartment of Environmental Studies, Institute of Graduate Studies and Research, Alexandria University, Alexandria, Egypt.
Manal ShalabyGenetic Engineering and Biotechnology Research Institute (GEBRI), City for Scientific Research and Technology Applications, New Borg Al-Arab City, Alexandria, Egypt.
Amira EmbabyDepartment of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Alexandria, Egypt.
Farid AtayaBiochemistry Department, College of Science, Riyadh, King Saud University, KSA.
Hoda MahmoudDepartment of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Alexandria, Egypt.
Ahmed HusseinDepartment of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Alexandria, Egypt.
Alexandria University · EGCity of Scientific Research and Technological Applications · EGKing Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current study highlights, for the first time, cloning, overexpression and purification of the novel interferon epsilon (IFNƐ), from the Arabian camel Camelus dromedaries. The study then assesses the cytotoxicity of IFNε against two human breast cancer cell lines MDA-MB-231 and MCF-7. Full-length cDNA encoding interferon epsilon (IFNε) was isolated and cloned from the liver of the Arabian camel, C. dromedarius using reverse transcription-polymerase chain reaction. The sequence analysis of the camel IFNε cDNA showed a 582-bp open reading frame encoding a protein of 193 amino acids with an estimated molecular weight of 21.230 kDa. A BLAST search analysis revealed that the C. dromedarius IFNε shared high sequence identity with the IFN genes of other species, such as Camelus ferus, Vicugna pacos, and Homo sapiens. Expression of the camel IFNε cDNA in Escherichia coli gave a fusion protein band of 24.97 kDa after induction with either isopropyl β-D-1-thiogalactopyranoside or lactose for 5 h. Recombinant IFNε protein was overexpressed in the form of inclusion bodies that were easily solubilized and refolded using SDS and KCl. The solubilized inclusion bodies were purified to apparent homogeneity using nickel affinity chromatography. We examined the effect of IFNε on two breast cancer cell lines MDA-MB-231 and MCF-7. In both cell lines, IFNε inhibited cell survival in a dose dependent manner as observed by MTT assay, morphological changes and apoptosis assay. Caspase-3 expression level was found to be increased in MDA-MB-231 treated cells as compared to untreated cells.

Indexed as

AnimalsAntineoplastic AgentsApoptosisCamelusCell SurvivalCloning, MolecularHumansInterferonsMaleMCF-7 CellsProtein FoldingSequence HomologyAntineoplastic AgentsInterferons

Identifiers

PMID31490936
PMCPMC6730848
OpenAlexW2971812507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.